ag 112 has been researched along with nsc 664704 in 3 studies
| Studies (ag 112) | Trials (ag 112) | Recent Studies (post-2010) (ag 112) | Studies (nsc 664704) | Trials (nsc 664704) | Recent Studies (post-2010) (nsc 664704) |
|---|---|---|---|---|---|
| 19 | 0 | 10 | 95 | 0 | 50 |
| Protein | Taxonomy | ag 112 (IC50) | nsc 664704 (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8335 | |
| Cyclin-T1 | Homo sapiens (human) | 0.064 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 0.4 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.47 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.4 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.5 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.4 | |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 0.4243 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 0.4243 | |
| Cyclin-A2 | Homo sapiens (human) | 0.73 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.73 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 9 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.064 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 0.023 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.0657 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.064 | |
| Cyclin-A1 | Homo sapiens (human) | 0.73 | |
| Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.6314 | |
| Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.6314 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 0.4 | |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 0.4243 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
3 other study(ies) available for ag 112 and nsc 664704
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |